US biotech company Gilead has filed a new revocation action with the UPC targeting a patent owned by the Chinese Academy of Military Medical Sciences. The patent could potentially disrupt sales of
When it comes to investing in biotech, it's best to look before you leap. The US Department of Commerce organized a SelectUSA Investment Seminar on June 6 to educate international investors
Zhejiang Hisun Biomaterials Co., Ltd. (Haisheng Biotech) recently announced an update on the latest progress of a criminal incidental civil action it initiated as the plaintiff. According to the
total 1 pages, 3 items